A Phase IV, Randomized, Open-label, Comparative, Single-center Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf (Modified Release Tacrolimus) and Prograf (Tacrolimus) in de Novo Living Donor Liver Transplant Recipients

Trial Profile

A Phase IV, Randomized, Open-label, Comparative, Single-center Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf (Modified Release Tacrolimus) and Prograf (Tacrolimus) in de Novo Living Donor Liver Transplant Recipients

Completed
Phase of Trial: Phase IV

Latest Information Update: 21 Jul 2017

At a glance

  • Drugs Tacrolimus (Primary) ; Tacrolimus
  • Indications Liver transplant rejection
  • Focus Pharmacokinetics
  • Acronyms MAIN
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 27 Oct 2015 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
    • 17 Oct 2012 Planned End Date changed from 1 Sep 2012 to 1 Aug 2014 as reported by ClinicalTrials.gov.
    • 26 Apr 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top